FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ester Zylber-Katz

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Physiology

Disorders

Obesity

Co-author Network

Publications

TOP 3
Tali Siegal; Ester Zylber-Katz
Strategies for increasing drug delivery to the brain: focus on brain lymphoma.
Ester Zylber-Katz; E Granot
Abrupt increase of tacrolimus blood levels during an episode of Shigella infection in a child after liver transplantation.
Micha Levy; Rifaat Safadi; Ester Zylber-Katz; L Granit; Yoseph Caraco
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ester Zylber-Katz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Tali Siegal; Ester Zylber-Katz
Strategies for increasing drug delivery to the brain: focus on brain lymphoma.
Clinical pharmacokinetics 2002;41(3):171-86.
2001: Ester Zylber-Katz; E Granot
Abrupt increase of tacrolimus blood levels during an episode of Shigella infection in a child after liver transplantation.
Therapeutic drug monitoring 2001;23(6):647-9.
2001: Micha Levy; Rifaat Safadi; Ester Zylber-Katz; L Granit; Yoseph Caraco
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
European journal of clinical pharmacology 2001;57(6-7):461-5.
2000: Ester Zylber-Katz; John Moshe Gomori; A Schwartz; Alexander Lossos; Felix Bokstein; Tali Siegal
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Clinical pharmacology and therapeutics 2000;67(6):631-41.
1999: Yoseph Caraco; Ester Zylber-Katz; M Fridlander; Dan Admon; Micha Levy
The effect of short-term dipyrone administration on cyclosporin pharmacokinetics.
European journal of clinical pharmacology 1999;55(6):475-8.
1999: Ester Zylber-Katz; Anthony Verstandig; Esther Granot
Influence of external biliary drainage on cyclosporin A (Neoral) absorption in a pediatric liver transplant recipient.
Pediatric transplantation 1999;3(3):243-5.
1999: Ester Zylber-Katz; Dafna Doron; Esther Granot
Conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients.
Transplantation proceedings 1999;31(4):1915-7.
1998: O Cohen; Ester Zylber-Katz; Yoseph Caraco; L Granit; Micha Levy
Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
European journal of clinical pharmacology 1998;54(7):549-53.
1998: Micha Levy; K Brune; Ester Zylber-Katz; O Cohen; Yoseph Caraco; G Geisslinger
Cerebrospinal fluid prostaglandins after systemic dipyrone intake.
Clinical pharmacology and therapeutics 1998;64(1):117-22.
1997: O Caspi; Ester Zylber-Katz; O Gotsman; Dana G Wolf; Yoseph Caraco
Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.
Therapeutic drug monitoring 1997;19(5):510-5.
1997: Micha Levy; I Leibowich; Ester Zylber-Katz; Y Ilan; L Granit; Sigal Sviri; Yoseph Caraco
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus.
Clinical pharmacology and therapeutics 1997;62(1):6-14.
1995: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Carbamazepine pharmacokinetics in obese and lean subjects.
The Annals of pharmacotherapy 1995;29(9):843-7.
1995: Ester Zylber-Katz; Yoseph Caraco; L Granit; M Levy
Dipyrone metabolism in liver disease.
Clinical pharmacology and therapeutics 1995;58(2):198-209.
1995: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Caffeine pharmacokinetics in obesity and following significant weight reduction.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19(4):234-9.
1995: Micha Levy; Ester Zylber-Katz; B Rosenkranz
Clinical pharmacokinetics of dipyrone and its metabolites.
Clinical pharmacokinetics 1995;28(3):216-34.
1995: Ester Zylber-Katz
Multiple drug interactions with cyclosporine in a heart transplant patient.
The Annals of pharmacotherapy 1995;29(2):127-31.
1995: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
European journal of clinical pharmacology 1995;47(6):525-30.
1994: Ester Zylber-Katz; Chaim Putterman; Yoseph Caraco
Multiple drug overdose in a kidney transplant patient.
Therapeutic drug monitoring 1994;16(3):327-31.
1993: Yoseph Caraco; Ester Zylber-Katz; L Granit; Micha Levy
Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
Arzneimittel-Forschung 1993;43(11):1204-8.
1992: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Significant weight reduction in obese subjects enhances carbamazepine elimination.
Clinical pharmacology and therapeutics 1992;51(5):501-6.
1992: Ester Zylber-Katz; L Granit; Micha Levy
Formation and excretion of dipyrone metabolites in man.
European journal of clinical pharmacology 1992;42(2):187-91.
1990: Yoseph Caraco; Ester Zylber-Katz; L Granit; M Levy
Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?
Biopharmaceutics & drug disposition 1990;11(7):639-43.
1989: Ester Zylber-Katz; L Granit
Cyclosporine blood concentrations determined by different assay methods in heart transplant patients.
Therapeutic drug monitoring 1989;11(5):592-7.
1989: Ester Zylber-Katz; L Granit; Jochanan Stessman; Micha Levy
Effect of age on the pharmacokinetics of dipyrone.
European journal of clinical pharmacology 1989;36(5):513-6.
1988: D Flusser; Ester Zylber-Katz; L Granit; Micha Levy
Influence of food on the pharmacokinetics of dipyrone.
European journal of clinical pharmacology 1988;34(1):105-7.
1986: G Koren; Ester Zylber-Katz; L Granit; M Levy
Pharmacokinetic studies of nifedipine and digoxin co-administration.
International journal of clinical pharmacology, therapy, and toxicology 1986;24(1):39-42.
1986: Ester Zylber-Katz; N Linder; L Granit; M Levy
Excretion of dipyrone metabolites in human breast milk.
European journal of clinical pharmacology 1986;30(3):359-61.
1985: Ester Zylber-Katz; L Granit; M Levy
Plasma protein binding of dipyrone metabolites in man.
European journal of clinical pharmacology 1985;29(1):67-71.
1984: Ester Zylber-Katz; L Granit; M Levy
Relationship between caffeine concentrations in plasma and saliva.
Clinical pharmacology and therapeutics 1984;36(1):133-7.
1984: Ester Zylber-Katz; G Koren; L Granit; M Levy
Bioavailability of nifedipine: a comparison between two preparations.
Biopharmaceutics & drug disposition 1984;5(2):109-15.
1984: Micha Levy; D Flusser; Ester Zylber-Katz; L Granit
Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.
European journal of clinical pharmacology 1984;27(4):453-8.